🔗 Share this article

An underground economy for unapproved weight-loss drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on recent findings.

Investigational Drug Acquiring Popularity Online

Retatrutide, which remains in research studies, is being advertised by online personalities for its supposed fat-burning properties. Viewers are urged to message these accounts privately for supplier links, while also receiving promotional offers.

Active Trade on Social Networks

Additionally, a robust trade exists on Telegram, where communities with numerous of participants share “before and after” photos, administration instructions and claims of next-day UK delivery. Vendors promote the substance there before directing customers to WhatsApp for purchases.

Learning About Retatrutide

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could assist individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.

Healthcare Professionals Express Worries

However, physicians and pharmacists have warned that the sale of what is still an unlicensed medication in the UK is a cause for concern and could lead to individuals injecting products of unknown origin.

Several experts stated the demand for the experimental drug could be linked to the increasing price of licensed slimming treatments such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that cannot be marketed or distributed for personal consumption under the British medical regulations.

Some content creators try to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach pharmaceutical, advertising, and consumer regulations, risking penalties, prosecution or imprisonment.

Platform Response and Material Elimination

According to TikTok, the service has taken down violative content and prohibited related hashtags and query recommendations. The company stated it was dedicated to keeping the service secure and investing in strengthening compliance measures.

Digital Trading Activities

Investigations also found groups with up to 9,000 members selling retatrutide using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” instantly displays groups with thousands of members, populated with images of weight loss, positive testimonials and detailed instructions for mixing or administering at home.

After moments of entering one group, a vendor shared WhatsApp details, where most transactions occur. The seller sent an instruction manual and guaranteed delivery within two days. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None asked about weight, health issues or previous experience.

Product Information and Costs

Within these groups, messages show dark colored parcels with postal service stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at home with sterile water, or pre-filled injectors usually sold at 160 pounds for 20 milligrams. When asked how long a injector should last, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Service Oversight and Safety Actions

A spokesperson for the messaging service stated it regularly monitored dangerous material on its service including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting substances they cannot confirm. Even if the research behind this drug is valid, these digital versions may not contain what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the increase in demand to recent price rises for approved slimming medications such as Mounjaro. “With costs rising, individuals are turning to social media. But counterfeit injections are highly risky. You can’t be certain what’s contained or whether the conditions they were produced in was sterile,” she explained.

Her staff has already seen patients injured by personal administration from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Producer Statement

A representative from Eli Lilly stated retatrutide was in third stage research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any item “falsely representing itself as a company investigational product not yet authorized … may subject patients to potentially serious medical dangers”.